Unibios HoldingsATH:BIOSK -0.38%64 EBITDA Margin % is 11.66% as of Dec. 2025, which is 25% below its 10-year median of 15.55. GuruFocus rates ATH:BIOSK with a GF Score™ of 64/100 and a GF Value™ of €1.47 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 3,033 Industrial Products companies, Unibios Holdings ranks better than 89.55% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Unibios Holdings's EBITDA for the
six
months ended in Dec. 2025 was €0.87 Mil. Unibios Holdings's Revenue for the
six
months ended in Dec. 2025 was €7.50 Mil. Therefore, Unibios Holdings's EBITDA margin for the quarter that ended in Dec. 2025 was 11.66%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Unibios Holdings EBITDA Margin % Related Terms
Unibios Holdings EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Unibios Holdings's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ATH:BIOSK vs VLTO, ZWS, CECO: EBITDA Margin % Comparison
For the Pollution & Treatment Controls subindustry, Unibios Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Unibios Holdings EBITDA Margin % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Unibios Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Unibios Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Unibios Holdings (ATH:BIOSK) has a EBITDA Margin % of 11.66% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Unibios Holdings and its competitors. This is 25% below median its historical median of 15.55. Over the past decade, Unibios Holdings' EBITDA Margin % has ranged from 5.51 to 26.37. According to the industry distribution chart, Unibios Holdings ranks #317 out of 3033 companies in the Industrial Products industry, placing it in the top 10.5%.
Is Unibios Holdings' EBITDA Margin % too high?
Unibios Holdings' current EBITDA Margin % of 11.66% is 25% below median its 10-year median of 15.55. Over the past 10 years, this metric has ranged from a low of 5.51 to a high of 26.37. The Industrial Products industry median EBITDA Margin % is 9.46. Unibios Holdings' value of 11.66% is 23.3% above this industry median. Based on the distribution chart, Unibios Holdings ranks #317 out of 3033 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers. Overall, Unibios Holdings has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Unibios Holdings' EBITDA Margin % compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, Unibios Holdings ranks #317 out of 3033 companies for EBITDA Margin %. This places Unibios Holdings in the top 11% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.46. Unibios Holdings' value of 11.66% is 23.3% above this benchmark. Historically, Unibios Holdings' own EBITDA Margin % has ranged from 5.51 to 26.37 over the past decade. While the company's 10-year median is 15.55 vs. the industry median of 9.46, Unibios Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Industrial Products company?
The median EBITDA Margin % among Industrial Products companies is 9.46, based on 3,033 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Unibios Holdings's current EBITDA Margin % of 11.66% is 23.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Unibios Holdings and its competitors. For the Industrial Products industry, the median EBITDA Margin % is 9.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Unibios Holdings's current EBITDA Margin % is 11.66%, which is 25% below median its own 10-year median of 15.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unibios Holdings stock overvalued right now?
Based on GuruFocus' analysis, Unibios Holdings (ATH:BIOSK) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.47, compared to a current price of €2.65 — trading 80.3% above its estimated fair value. The current EBITDA Margin % is 11.66%, which is 25% below median its 10-year median of 15.55 and 23.3% above the Industrial Products industry median of 9.46. Unibios Holdings' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Unibios Holdings (ATH:BIOSK), the current EBITDA Margin % is 11.66% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Unibios Holdings (ATH:BIOSK) Overvalued in 2026?
Based on GuruFocus' analysis, Unibios Holdings stock appears to be overvalued.
The current stock price of €2.65 is trading 80.3% above its estimated GF Value™ of €1.47.
GuruFocus considers Unibios Holdings to be Significantly Overvalued.
Key valuation signals for ATH:BIOSK:
EBITDA Margin %: 11.66% (25% below median its 10-year median of 15.55)
GF Value™: €1.47 vs. price of €2.65 (80.3% above fair value)
Industry Position: 23.3% above the Industrial Products median (#317 of 3033)
No single metric tells the full story. See the ATH:BIOSK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Unibios Holdings SA, through its subsidiaries, provides technologies for the responsible use of water and energy. Its activities include the treatment, filtration, water management, heating, and air conditioning, combined with energy saving.
64GF Score
Get the complete analysis for ATH:BIOSK
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ATH:BIOSK has been successfully added to your 
